Unraveling the Beneficial Role of Resveratrol in Fructose-Induced Non-Alcoholic Steatohepatitis with a Focus on the AMPK/Nrf2 Signaling Axis. [PDF]
Zakaria SS, Hanafy SM.
europepmc +1 more source
ABSTRACT Background Lipid deposition in alcoholic fatty liver disease (AFL) represents an early stage in alcoholic liver disease progression and may contribute to carcinogenesis. MicroRNAs (miRNAs) play critical regulatory roles in liver biological processes. Methods In this study, we explored the miR‐18a‐5p/CYP1A1/PPAR axis in AFL using bioinformatics
XueMei Zhang +10 more
wiley +1 more source
Genetic variants underlying precancerous conditions of hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero +7 more
wiley +1 more source
L-carnitine attenuates autophagic flux, apoptosis, and necroptosis in rats with dexamethasone-induced non-alcoholic steatohepatitis. [PDF]
Amer AE +4 more
europepmc +1 more source
Exploring the alleviating effects of Bifidobacterium metabolite lactic acid on non-alcoholic steatohepatitis through the gut-liver axis. [PDF]
Zhao H +6 more
europepmc +1 more source
Exploring Mechanisms of Lang Qing Ata in Non-Alcoholic Steatohepatitis Based on Metabolomics, Network Pharmacological Analysis, and Experimental Validation. [PDF]
Li S +7 more
europepmc +1 more source
Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function. [PDF]
Mun D +8 more
europepmc +1 more source
Progression from Non-alcoholic Steatohepatitis to Advanced Liver Diseases and Mortality Among Medicare Patients. [PDF]
Kim Y +4 more
europepmc +1 more source

